Day: March 19, 2026

MISSISSAUGA, Ontario, March 19, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. Key highlights include:(CAD) Q4 2025   % Changevs.Q4 2024   FY 2025   % Change vs. FY 2024  Canadian Pharma Sales 8,792,653   +3 % 37,143,783   +13 %International Pharma Sales 601,387   +240 % 3,735,959   +302 %Legacy Business Sales 277,883   +278 % 2,172,241   +86 %Total Company Sales 9,671,923   +10 % 43,051,983   +23 %EBITDA1 2,528,561   +13 % 12,122,756   +30 %Net Income After Taxes (NIAT) 1,991,788   +23 % 9,012,232   +24 %Fully Diluted EPS 0.17   +25 % 0.78   +27 %Return on Average Equity for FY 2025 was 24% as compared to 21% for FY 2024 During FY 2025, repurchased for cancellation a total...

Ramat Gan, Israel, March 19, 2026 (GLOBE NEWSWIRE) — Odysight.ai Inc. (NASDAQ: ODYS), a leader in AI-powered visual sensing and predictive maintenance (PdM) solutions for the aerospace, defense, and industrial markets, today announces its full year 2025 financial results and provides a business update. Key Full Year 2025 Highlights:  ● Vision-based PdM/CBM platform revenues grew approximately 23% year-over-year, reflecting increasing commercial adoption across aerospace and industrial customers.       ● Backlog2 of approximately $13.8 million as of December 31, 2025, providing revenue visibility into 2026 and the following years. Monetization of backlog commenced in 2025.       ● Cash balance1 of approximately $26 million as of December 31, 2025, no debt.       ● Significant aerospace and defense milestones:...

Your vote is important no matter how many Allied Gold shares you own. The Board of Directors of Allied Gold Corporation unanimously recommends that Shareholders vote FOR the Arrangement Resolution. Shareholders who have questions or need assistance with voting may contact Allied Gold’s proxy solicitation agent, Laurel Hill Advisory Group, by calling or texting “INFO” to 1-877-452-7184 (toll free in North America), or 1-416-304-0211 (collect outside of North America), or by e-mail at assistance@laurelhill.com.TORONTO, March 19, 2026 (GLOBE NEWSWIRE) — Allied Gold Corporation (“Allied Gold” or the “Company”) (TSX: AAUC, NYSE: AAUC) is pleased to announce that two leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co. LLC (“Glass Lewis”) have...

TORONTO, March 19, 2026 (GLOBE NEWSWIRE) — (TSX: CGX) – Cineplex Inc. (“Cineplex” or the “Company”), Canada’s leading entertainment and media company, today announced the first amendment to its Bank Credit Agreement which extends the maturity date from March 4, 2027 to either September 18, 2028 (if existing 7.625% senior secured notes due March 31, 2029 have not been repaid, redeemed or refinanced in full) or March 18, 2029 (the “Bank Credit Agreement”). The amendment also provides for the replacement of certain benchmark reference rates (from “Adjusted Term SOFR” to “Term SOFR”) and provides additional flexibility with respect to permitted distributions and debt repayments, prepayments or redemptions in connection with property sales subject to certain existing restrictions under Cineplex’s debt agreements. A copy of this amendment...

Company announcement – No. 4 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, March 19, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has by decision of the Board of Directors increased its share capital by a nominal amount of DKK 10,530 divided into 10,530 new shares with a nominal value of DKK 1 each. The capital increase is a consequence of the exercise of warrants granted under one of Zealand Pharma’s employee warrant programs. Employee warrant programs are part of Zealand Pharma’s incentive scheme. Each warrant gives the owner the right to subscribe for one newly issued Zealand Pharma share at a prespecified...

(All dollar amounts are expressed in U.S. dollars, unless otherwise noted.) TORONTO, March 19, 2026 (GLOBE NEWSWIRE) — Kinross Gold Corporation (“Kinross” or the “Company”) (TSX: K, NYSE: KGC) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has accepted the notice filed by the Company to renew its normal course issuer bid (“NCIB”) program. Under the NCIB program, the Company is authorized to purchase up to 104,239,211 of its common shares (out of the 1,197,584,004 common shares outstanding as at March 12, 2026) representing up to 10% of the Company’s public float of 1,042,392,116 common shares, during the period starting on March 24, 2026 and ending on March 23, 2027. The Company believes that the market price of the common shares may not, from time to time, fully reflect their value and accordingly the purchase...

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, March 19, 2026 (GLOBE NEWSWIRE) — Northview Residential REIT (the “REIT”) today announced its March 2026 cash distribution amounts on its outstanding Class A Units, Class C Units and Class F Units (collectively, the “Units”) in the amount of C$0.091146 per Unit (C$1.09 per Unit on an annualized basis). The distribution will be payable on April 15, 2026 to holders of Units of record at March 31, 2026. Tax Information Regarding 2025 Distributions For the year ended December 31, 2025, the income allocation for the monthly and December special distributions to Unitholders will consist of 100% capital gains, primarily due to the sale of non-core assets throughout 2025. Unitholders should note that this allocation is specific to...